Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
Muhammad Shaheer Bin Faheem, RCOP Mentor at Research Council of Pakistan, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thrombosis and Thrombolysis, adding:
“Thrilled to share that our recently published study in the Journal of Thrombosis and Thrombolysis, titled ‘A Growing Mortality Divide: Demographic and Regional Disparities in Thromboembolism with Hypertension, U.S. 1999–2023,’ is now available online.
Using 25 years of CDC WONDER mortality data, we examined how deaths involving both thromboembolism and hypertension have changed across different demographic and geographic groups in the United States.
The findings show a clear and concerning pattern.
Mortality increased substantially over time, with important disparities by sex, race, age, and region. Non-Hispanic African Americans had the highest mortality burden among racial groups, while older adults experienced markedly higher rates than younger populations.
Mortality was also higher in nonmetropolitan areas and in the Southern United States.
Overall, 187,872 deaths involving both thromboembolism and hypertension were identified between 1999 and 2023.
These findings highlight the need for more targeted prevention, better recognition of high-risk populations, and more equitable allocation of healthcare resources.”
Title: A Growing mortality divide: demographic and regional disparities in thromboembolism with hypertension, U.S. 1999–2023
Authors: Muhammad Shaheer Bin Faheem, Own E. Mohammad Najmi, Usman Ahmad, Mahad Ahmad, Ammar Yahya, Sanhia Maheshwari, Ashish Ashok Lal

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:13Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory
-
Sep 26, 2026, 07:01David McIntosh: Plasma Derived Medicines and the Global Access Gap
-
Sep 26, 2026, 06:49Heghine Khachatryan: Navigating the Complexities of Pediatric VTE
-
Sep 26, 2026, 06:44Emmanuel J Favaloro: A Century of von Willebrand Disease 2026 Virtual Issue
-
Sep 26, 2026, 05:12Saja Al-Zamili: Dual Antithrombotic Therapy After Ischemic Stroke in Atrial Fibrillation – A Meta-Analysis